Clinical Trials Browser

Phase 2 × patritumab deruxtecan × Other solid neoplasm × Clear all

NCT06383884 2025-12-15

Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult